Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CDK4 or CDK6 upregulation induces DNA replication stress and genomic instability to cause EGFR targeted therapy resistance in lung cancer.
Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025
Risk and protective factors for sudden infant death syndrome (SIDS) in low-resource communities in Kolkata India: a mixed methods exploratory study of semi-structured interviews and survey data.
Journal: Frontiers in pediatrics
Published: June 24, 2025
Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer.
Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 06, 2025
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 19, 2024
Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.
Journal: Nature communications
Published: September 12, 2023
Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC.
Journal: Cancer discovery
Published: December 20, 2022
Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 15, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026